The role of free kappa and lambda light chains in the pathogenesis and treatment of inflammatory diseases - ScienceDirect
Immunoglobulin Kappa Chain - an overview | ScienceDirect Topics
Living With - HealthTree for Myeloma
VpreB surrogate light chain expression in B-lineage ALL: a report from the Children's Oncology Group - ScienceDirect
Light Chain Myeloma: Symptoms, Treatment, Outlook, More
Frontiers | High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis
Serum-free light-chain assay: clinical utility and limitations - Malini V Bhole, Ross Sadler, Karthik Ramasamy, 2014
Light Chain Multiple Myeloma: Your Ultimate Guide | MyMyelomaTeam
The Proximal Tubule Toxicity of Immunoglobulin Light Chains - Kidney International Reports
Subset of Kappa and Lambda Germline Sequences Result in Light Chains with a Higher Molecular Mass Phenotype | Journal of Proteome Research
Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS
Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
Polyclonal free light chains: promising new biomarkers in inflammatory | CBF
Polyclonal free light chains: promising new biomarkers in inflammatory | CBF
Light Chain Myeloma: Symptoms, Treatment, Outlook, More
Free Light Chains as a Novel Diagnostic Biomarker of Immune System Abnormalities in Multiple Sclerosis and HIV Infection
Light chain multiple myeloma: Definition, diagnosis, and outlook
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect
Subset of Kappa and Lambda Germline Sequences Result in Light Chains with a Higher Molecular Mass Phenotype | Journal of Proteome Research
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
Evaluation of monoclonal gammopathies - Differential diagnosis of symptoms | BMJ Best Practice US
Prognostic impact of rapid reduction of involved free light chains in multiple myeloma patients under first-line treatment with Bendamustine, Prednisone, and Bortezomib (BPV) | SpringerLink